A new research paper co-authored by Dr. Lili Wang tracks advances in nanotechnology-based therapies in new treatments for various cancers.
The study finds a sharp increase in nanotech cancer therapies since the late 2000s, partly driven by the high mortality rates of pancreatic and brain cancer.
The research also highlights worldwide nanotech leaders for specific cancers: Switzerland in prostate cancer, Japan in colon cancer, China in ovarian cancer and Greece in pancreatic cancer.
These ground-breaking technologies are, say the authors, blazing a trail in biomedicine and generating a revolution in clinical practice; a revolution that could lead to more effective anticancer treatments in the near future. See the video above and paper below for more details.
Image: Wellcome / A. Weston
Video: UNU / H. Hudson